Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Tg Therapeuticscmn (TGTX)
Tg Therapeuticscmn (TGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Why TG Therapeutics Stock Is Crushing It Today

The biopharmaceutical company's Q3 update was music to investors' ears.

TGTX : 13.53 (+5.62%)
TG Therapeutics: Q3 Earnings Snapshot

TG Therapeutics: Q3 Earnings Snapshot

TGTX : 13.53 (+5.62%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TG Therapeutics, Inc. - TGTX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of TG Therapeutics, Inc. ("TG Therapeutics" or the "Company") (NASDAQ: TGTX). Such...

TGTX : 13.53 (+5.62%)
Why TG Therapeutics Stock Is Crashing Today

The drugmaker delivered a couple of surprises in Q2.

TGTX : 13.53 (+5.62%)
TG Therapeutics: Q2 Earnings Snapshot

TG Therapeutics: Q2 Earnings Snapshot

TGTX : 13.53 (+5.62%)
Why Apellis Pharmaceuticals, TG Therapeutics, and Viking Therapeutics Were on the Move Today

These three biotech stocks were on the volatile side today.

APLS : 61.12 (+13.46%)
TGTX : 13.53 (+5.62%)
VKTX : 12.88 (+5.40%)
ISEE : 39.95 (+0.38%)
ALPMY : 12.2375 (+0.64%)
TG Therapeutics (TGTX) Reports Q1 Loss, Tops Revenue Estimates

TG Therapeutics (TGTX) delivered earnings and revenue surprises of 22.22% and 105.94%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

TGTX : 13.53 (+5.62%)
ICUI : 90.43 (+3.04%)
TG Therapeutics: Q1 Earnings Snapshot

TG Therapeutics: Q1 Earnings Snapshot

TGTX : 13.53 (+5.62%)
3 Top Biotech Stocks Defying the Bear Market

All three companies have therapies with strong sales potential.

BIIB : 233.02 (-0.45%)
LLY : 584.43 (-1.12%)
NVS : 97.95 (+0.05%)
RHHBY : 34.4100 (+2.14%)
TGTX : 13.53 (+5.62%)
VKTX : 12.88 (+5.40%)
BGNE : 186.61 (-0.18%)
Why Shares of TG Therapeutics Soared on Tuesday

Early reports of strong sales for its recently approved multiple sclerosis drug gave the stock a jolt.

TGTX : 13.53 (+5.62%)

Barchart Exclusives

3 Top Growth Stocks to Buy for December 2023
Here are three of the best growth stocks to buy right now, based on solid earnings performance, encouraging 2024 forecasts, and enthusiastic ratings from Wall Street analysts. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar